Cardiology (all articles)
Cohort study: Dietary inflammatory potential and risk of cardiovascular disease among men and women in the U.S.
3 Nov, 2020 | 03:05h | UTCCommentary: High Intake of Proinflammatory Foods Linked to CVD Risk – NEJM Journal Watch∗
The value of urinary sodium assessment in acute heart failure
3 Nov, 2020 | 03:02h | UTC
Five things clinicians and patients should question in Pediatric Cardiology
3 Nov, 2020 | 02:59h | UTCCommentary: Choosing Wisely: Practices to Question in Pediatric Cardiology – NEJM Journal Watch
See complete lists of low-value practices: Choosing Wisely U.S. / Choosing Wisely UK / Choosing Wisely Australia AND Choosing Wisely Canada
Expert analysis: Efficacy and safety of colchicine in patients with chronic stable coronary disease
2 Nov, 2020 | 02:18h | UTC
AHA Scientific Statement: Prevention of complications in the cardiac intensive care unit
30 Oct, 2020 | 01:06h | UTCCommentary: New strategies suggested for critical heart care in the ICU – American Heart Association
Systematic review: PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease
29 Oct, 2020 | 08:57h | UTCSummary: PCSK9 inhibitors for prevention of cardiovascular disease – Cochrane Library
The ‘Ten Commandments’ in the new ESC Adult Congenital Heart Disease Guidelines
29 Oct, 2020 | 08:59h | UTCOriginal guideline and commentaries: 2020 ESC Guidelines for the management of adult congenital heart disease
Covid-19 and the athletic heart: Emerging perspectives on pathology, risks, and return to play
28 Oct, 2020 | 09:06h | UTCAuthor Interview: COVID-19 and the Athletic Heart: Emerging Perspectives on Pathology, Risks, and Return-to-Play
Commentary on Twitter
The heart in athletes with #Covid19.
Summary of knowledge base, which is limited, and recommendations for rest and return to play https://t.co/4JBVO7nvAE @JAMACardio— Eric Topol (@EricTopol) October 26, 2020
Observational Study: Ticagrelor, compared with clopidogrel, is not associated with better outcomes for patients with ACS treated with PCI
28 Oct, 2020 | 08:54h | UTCAssociation of Ticagrelor vs Clopidogrel With Net Adverse Clinical Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention – JAMA (free for a limited period)
Editorial: Net Adverse Clinical Events With Antiplatelet Therapy in Acute Coronary Syndromes – JAMA (free for a limited period)
Author Interview: Ticagrelor or Clopidogrel for Antiplatelet Therapy After Percutaneous Intervention for Acute Coronary Syndrome? – JAMA
Commentary on Twitter
In @JAMA_current, our article comparing ticagrelor and clopidogrel in patients with an acute coronary syndrome undergoing PCI. A remarkable international collaboration. Bottom line: more expensive med not better. https://t.co/SDAyI7Q1MV pic.twitter.com/RFmmy4qvrW
— Harlan Krumholz (@hmkyale) October 27, 2020
JACC Journal series gives in-depth look at COVID-19’s impact on the heart
27 Oct, 2020 | 09:49h | UTCNews release: Journal series gives in-depth look at COVID-19’s impact on the heart – American College of Cardiology
JACC Focus Seminar 1: Coronavirus and Cardiometabolic Syndrome
JACC Focus Seminar 2: Coronavirus Historical Perspective, Disease Mechanisms, and Clinical Outcomes
JACC Focus Seminar 3: Coronavirus and Cardiovascular Disease, Myocardial Injury, and Arrhythmia
Observational study on the effectiveness of deep sedation for patients with intractable electrical storm refractory to antiarrhythmic drugs
27 Oct, 2020 | 09:34h | UTC
Commentary on Twitter
Effectiveness of deep sedation for patients with intractable electrical storm refractory to anti-arrhythmic drugs https://t.co/sY7R3rtdvF #AHAJournals @MartinsRaphae15 @EloiMarijon pic.twitter.com/7SD3epIUUi
— Circulation (@CircAHA) October 23, 2020
Perspective: COVID-19 can affect the heart
25 Oct, 2020 | 23:39h | UTCCOVID-19 can affect the heart – Science
Commentary from the author
https://twitter.com/EricTopol/status/1320427201351745536
The ‘Ten Commandments’ for the 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
25 Oct, 2020 | 23:25h | UTCOriginal guideline and commentaries: 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
[Abstract only] Preliminary study suggests age-adjusted D-dimer can exclude left atrial thrombus in patients with atrial fibrillation
25 Oct, 2020 | 23:26h | UTCD-dimer blood concentrations to exclude left atrial thrombus in patients with atrial fibrillation – Heart (link to abstract – $ for full-text)
Commentary on Twitter
A nice study on the use of D-dimer for excluding left atrial thrombus.
Patients with D-dimer < (10 x patient's age) had 100% sensitivity and NPV for excluding LA thrombus.
This represented 60% of the population, who could in theory safely avoid TOE. https://t.co/OFUy9caWd0
— Mark Mills (@DrMarkMills) October 25, 2020
2020 ACC Expert Consensus: Management of conduction disturbances in patients undergoing Transcatheter Aortic Valve Replacement
23 Oct, 2020 | 09:00h | UTCCommentary: ACC Releases Guidance on Management of Conduction Disturbances in TAVR – American College of Cardiology
[Abstract Only] Redevelopment and validation of the SYNTAX score II to predict the benefit of PCI vs. CABG in patients with complex coronary artery disease
23 Oct, 2020 | 08:59h | UTCSee calculator: SYNTAX Score II calculator
New 2020 AHA Guidelines for CPR and emergency cardiovascular care in adults and children
22 Oct, 2020 | 09:47h | UTCHighlights: 2020 AHA Guidelines Update for CPR and ECC
Executive Summary: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care
Meta-analysis: Dual antiplatelet therapy after percutaneous coronary intervention and drug-eluting stents
22 Oct, 2020 | 09:29h | UTC
AHA Scientific Statement: Contemporary diagnosis and management of rheumatic heart disease
20 Oct, 2020 | 01:34h | UTCTop Things to Know: Contemporary Diagnosis and Management of Rheumatic Heart Disease – American Heart Association
[Abstract Only] Meta-analysis: Effect of urate-lowering therapy on cardiovascular and kidney outcomes
20 Oct, 2020 | 01:22h | UTCEffect of Urate-Lowering Therapy on Cardiovascular and Kidney Outcomes: A Systematic Review and Meta-Analysis – Clinical Journal of the American Society of Nephrology (link to abstract – $ for full-text)
Commentary on Twitter
Study found urate-lowering therapy didn't produce benefits on clinical outcomes including major adverse cardiovascular events, all-cause mortality & kidney failure. Insufficient evidence to support urate lowering to improve kidney & cardiovascular outcomes https://t.co/uifm4vikYe pic.twitter.com/3fV60V3Lcx
— CJASN (@CJASN) October 14, 2020
NIHR dynamic review of the evidence around ongoing Covid19 symptoms (often called Long Covid)
18 Oct, 2020 | 23:14h | UTCA dynamic review of the evidence around ongoing Covid19 symptoms (often called Long Covid) – National Institute for Health Research
News Release: Living with COVID: NIHR publishes dynamic themed review into ‘ongoing COVID’
Commentaries: Coronavirus: ‘Long Covid could be four different syndromes’ – BBC AND Long covid could be four different syndromes, review suggests – The BMJ AND ‘Long COVID’ may affect multiple parts of body and mind, doctors say – Reuters
Study: Real-world blood pressure measurements vs. measurements taken in the SPRINT trial
15 Oct, 2020 | 09:00h | UTCCommentaries: A Tale of 2 Blood Pressures – JAMA Internal Medicine AND Real-World BP Measurements vs SPRINT Protocol – Physician’s Weekly
Commentary on Twitter
Incredibly important paper in @JAMAInternalMed demonstrating poor concordance between clinic blood pressure and trial based blood pressure. https://t.co/waLTYk9Lnu
— Stephen Juraschek MD, PhD, FAHA, AHSCP-CHS (@spjuraschek) October 13, 2020
Study: Polypharmacy (taking > 10 medications) is common in older patients with heart failure
15 Oct, 2020 | 09:03h | UTCPolypharmacy in Older Adults Hospitalized for Heart Failure – Circulation: Heart Failure
Commentaries: Ten or more medications, often prescribed to older heart failure patients, raises concerns – American Heart Association AND Polypharmacy Common Among Older Heart Failure Patients – Physician’s Weekly
Commentary on Twitter
New work from @OzanUnluMD @ParagGoyalMD indicates that polypharmacy (taking > 10 medications) is common in older patients with #heartfailure, and is primarily due to non-cardiovascular meds #AHAJournals @WeillCornell | https://t.co/hL0GZLaCnT pic.twitter.com/BHppxDQgor
— Circ: Heart Failure (@CircHF) October 13, 2020
Non-respiratory presentations of COVID-19, a clinical review
14 Oct, 2020 | 09:33h | UTC
Meta-analysis: Nonpharmacologic interventions for reducing blood pressure in adults with prehypertension to established hypertension
14 Oct, 2020 | 09:20h | UTC
Commentary on Twitter
Which lifestyle intervention works best for hypertension? #Bayesian meta-analysis suggests the #DASH diet https://t.co/1CgLVwN4LB #AHAJournals @tinauchojo pic.twitter.com/wzJ87OPT0m
— JAHA (@JAHA_AHA) October 5, 2020